Palisade Bio Stock (NASDAQ: PALI) stock price, news, charts, stock research, profile.
Open | $3.60 |
Close | $3.59 |
Volume / Avg. | 5.57K / 63.70K |
Day Range | $3.42 - $3.67 |
52 Wk Range | 3.30 - 28.95 |
Market Cap | $4.03M |
P/E Ratio | 0.02 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.
Other companies in Palisade Bio’s space includes: Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Portage Biotech (NASDAQ:PRTG) and Trevena (NASDAQ:TRVN).
Palisade Bio has a consensus price target of $19.25.
The stock price for Palisade Bio (NASDAQ: PALI) is $3.59 last updated September 6, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Palisade Bio.
Palisade Bio’s Q3 earnings are confirmed for Friday, November 8, 2024.
There is no upcoming split for Palisade Bio.
Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.